Literature DB >> 21593257

Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene.

Fernanda S Spies1, Andrezza W Ribeiro, Daniela F Ramos, Marta O Ribeiro, Anandi Martin, Juan Carlos Palomino, Maria Lucia R Rossetti, Pedro Eduardo A da Silva, Arnaldo Zaha.   

Abstract

Mutations related to streptomycin resistance in the rpsL and rrs genes are well known and can explain about 70% of this phenotypic resistance. Recently, the gidB gene was found to be associated with low-level streptomycin resistance in Mycobacterium tuberculosis. Mutations in gidB have been reported with high frequency, and this gene appears to be very polymorphic, with frameshift and point mutations occurring in streptomycin-susceptible and streptomycin-resistant strains. In this study, mutations in gidB appeared in 27% of streptomycin-resistant strains that contained no mutations in the rpsL or rrs genes, and they were associated with low-level streptomycin resistance. However, the association of certain mutations in gidB with streptomycin resistance needs to be further investigated, as we also found mutations in gidB in streptomycin-susceptible strains. This occurred only when the strain was resistant to rifampin and isoniazid. Two specific mutations appeared very frequently in this and other studies of streptomycin-susceptible and -resistant strains; these mutations were not considered related to streptomycin resistance, but as a polymorphism. We stratified the strains according to the different phylogenetic lineages and showed that the gidB(16) polymorphism (16G allele) was exclusively present in the Latin American-Mediterranean (LAM) genotype, while the gidB(92) polymorphism (92C allele) was associated with the Beijing lineage in another population. In the sample studied, the two characterized single-nucleotide polymorphisms could distinguish LAM and Beijing lineages from the other lineages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593257      PMCID: PMC3147840          DOI: 10.1128/JCM.00168-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Molecular determinants of drug resistance in tuberculosis.

Authors:  P F Riska; W R Jacobs; D Alland
Journal:  Int J Tuberc Lung Dis       Date:  2000-02       Impact factor: 2.373

2.  Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Authors:  Thomas C Victor; Petra E W de Haas; Annemarie M Jordaan; Gian D van der Spuy; Madalene Richardson; D van Soolingen; Paul D van Helden; Robin Warren
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Molecular characterisation of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland.

Authors:  A Brzostek; A Sajduda; T Sliwiński; E Augustynowicz-Kopeć; A Jaworski; Z Zwolska; J Dziadek
Journal:  Int J Tuberc Lung Dis       Date:  2004-08       Impact factor: 2.373

4.  Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism.

Authors:  Fernanda S Spies; Pedro E Almeida da Silva; Marta O Ribeiro; Maria Lucia Rossetti; Arnaldo Zaha
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

5.  Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance.

Authors:  T C Victor; A van Rie; A M Jordaan; M Richardson; G D van Der Spuy; N Beyers; P D van Helden; R Warren
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

6.  Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan.

Authors:  M Fukuda; H Koga; H Ohno; B Yang; Y Hirakata; S Maesaki; K Tomono; T Tashiro; S Kohno
Journal:  J Antimicrob Chemother       Date:  1999-02       Impact factor: 5.790

7.  Microevolution of the direct repeat region of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data.

Authors:  R M Warren; E M Streicher; S L Sampson; G D van der Spuy; M Richardson; D Nguyen; M A Behr; T C Victor; P D van Helden
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Streptomycin resistance in mycobacteria.

Authors:  N Honoré; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

10.  Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives.

Authors:  C Sola; I Filliol; M C Gutierrez; I Mokrousov; V Vincent; N Rastogi
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

View more
  31 in total

Review 1.  Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors:  N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-07       Impact factor: 3.267

2.  The roles of rpsL, rrs, and gidB mutations in predicting streptomycin-resistant drugs used on clinical Mycobacterium tuberculosis isolates from Hebei Province, China.

Authors:  Yuling Wang; Qianlin Li; Huixia Gao; Zhi Zhang; Yuzhen Liu; Jianhua Lu; Erhei Dai
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa.

Authors:  Neel R Gandhi; Darren Weissman; Prashini Moodley; Melissa Ramathal; Inga Elson; Barry N Kreiswirth; Barun Mathema; Elena Shashkina; Richard Rothenberg; Anthony P Moll; Gerald Friedland; A Willem Sturm; N Sarita Shah
Journal:  J Infect Dis       Date:  2012-11-19       Impact factor: 5.226

4.  Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype.

Authors:  Cristina Villellas; Liselotte Aristimuño; María-Asunción Vitoria; Cristina Prat; Silvia Blanco; Darío García de Viedma; José Domínguez; Sofía Samper; José A Aínsa
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

Review 5.  Circulation of M. tuberculosis Beijing genotype in Latin America and the Caribbean.

Authors:  M I Cerezo-Cortés; J G Rodríguez-Castillo; R Hernández-Pando; M I Murcia
Journal:  Pathog Glob Health       Date:  2020-01-05       Impact factor: 2.894

6.  Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting.

Authors:  Silke Feuerriegel; Barbara Oberhauser; Abu Garawani George; Foday Dafae; Elvira Richter; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  BMC Microbiol       Date:  2012-05-30       Impact factor: 3.605

7.  High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Danny C T Ong; Joshua C L Wong; Gilman K H Siu; Wing-Cheong Yam
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

8.  High Resolution Melting Curve Analysis for Rapid Detection of Streptomycin and Ethambutol Resistance in Mycobacterium tuberculosis.

Authors:  Faranak Rezaei; Mehri Haeili; Abbasali Imani Fooladi; Mohammad Mehdi Feizabadi
Journal:  Maedica (Bucur)       Date:  2017-12

9.  Heterogeneous Streptomycin Resistance Level Among Mycobacterium tuberculosis Strains From the Same Transmission Cluster.

Authors:  Deisy M G C Rocha; Carlos Magalhães; Baltazar Cá; Angelica Ramos; Teresa Carvalho; Iñaki Comas; João Tiago Guimarães; Helder Novais Bastos; Margarida Saraiva; Nuno S Osório
Journal:  Front Microbiol       Date:  2021-06-11       Impact factor: 5.640

10.  Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea.

Authors:  Marie Ballif; Paul Harino; Serej Ley; Mireia Coscolla; Stefan Niemann; Robyn Carter; Christopher Coulter; Sonia Borrell; Peter Siba; Suparat Phuanukoonnon; Sebastien Gagneux; Hans-Peter Beck
Journal:  BMC Microbiol       Date:  2012-09-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.